Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Infections, Legionella pneumophila

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Infections, Legionella pneumophila in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J1
Cai, S1
Li, R1
Xie, J1
Yang, F1
Liu, T1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Infections, Legionella pneumophila

ArticleYear
Blockade of Cycloxygenase-2 ameliorates sepsis induced immune-suppression by regulating myeloid-derived suppressor cells.
    International immunopharmacology, 2022, Volume: 104

    Topics: Animals; CD4-Positive T-Lymphocytes; Cecum; Cyclooxygenase 2 Inhibitors; Cytokines; Disease Models,

2022